Abstract
Melanoma has been referred to as the Australian malignancy, and unfortunately this epithet is justified. The incidence in Australia (and New Zealand) is approximately three times higher than in the United States and four times higher than in the UK and Europe [1]. The reasons for this disparity in incidence for populations with a similar genetic background (predominantly Caucasian/Anglo Saxon) are multifactorial but include high ambient UV levels (Australia is located in comparatively low latitudes, close to the equator) and a favourable climate that predisposes to extended periods outdoors and, until recently, poor understanding of the importance of sun avoidance behaviours. Cutaneous malignancy (including squamous cell carcinoma and basal cell carcinoma as well as melanoma) is a major public health issue for Australia. Surveillance involves large numbers of patients who, in addition to the risks from their index primary lesion, remain at significantly increased risk for the subsequent development of both melanoma and non-melanoma skin cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN2002: cancer, mortality and prevalence worldwide. IARC cancerbase No 5. version 2.0 2004. Lyon: IARC Press. http://www-dep.iarc.fr/
Australian Institute of Health and Welfare, Cancer Australia & Australasian Association of Cancer Registries 2008. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer Series no. 42. Cat. no. CAN 38. Canberra: AIHW. http//www.aihw.gov.au
Canstat: cancer In Victoria 2005. The Cancer Council Victoria Epidemiology Centre 2008 No 45, February 2008. http//www.cancervic.org.au.
Tracey EA, Baker D, Chen W, Stavrou E, Bishop J. Cancer in New South Wales: incidence, mortality and prevalence 2005. 2007. Sydney: Cancer Institute NSW Incidence
Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington (2008). http//www.cancer.org.au
Nieweg OE, Kroon BB. The conundrum of follow-up: should it be abandoned? Surg Oncol Clin N Am. 2006;15(2):319–30.
Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol. 2005;6(8):608–21.
Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol. 2008;15(5):1476–84. Epub 2008 Jan 15.
Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14(6):1924–33.
Francken AB, Shaw HM, Thompson JF. Detection of second primary cutaneous melanomas. Eur J Surg Oncol. 2008;34(5):587–92.
McCaul KA, Fritschi L, Baade P, Coory M. The incidence of second primary invasive melanoma in Queensland, 1982–2003. Cancer Causes Control. 2008;19(5):451–8.
Kelly JW, Henderson MA, Thursfield VJ, Slavin J, Ainslie J, Giles GG. The management of primary cutaneous melanoma in Victoria in 1996 and 2000. Med J Aust. 2007;187(9):511–4.
Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, et al. Follow-up schedules after treatment for malignant melanoma. Br J Surg. 2008;95(11):1401–7.
Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 2004;5(11):673–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this chapter
Cite this chapter
Henderson, M.A. (2013). Cutaneous Melanoma Surveillance Counterpoint: Australia. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_51
Download citation
DOI: https://doi.org/10.1007/978-1-60327-969-7_51
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-968-0
Online ISBN: 978-1-60327-969-7
eBook Packages: MedicineMedicine (R0)